The impact of the intensity of serial automated plasmapheresis and the speed of deep-freezing on the quality of plasma

Transfusion

Volumn 41, Issue 12, 2001, Pages 1601-1605

  Hellstern, Peter ^a   Bach, Jürgen ^a   Haubelt, Hannelore ^a   Hitzler, Walter E ^a   Mathis, Sabine ^a   Vogt, Anette ^a  

^a Inst Hamostaseol/Transfusionsmed   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CITRIC ACID; D DIMER; FIBRINOGEN; IMMUNOGLOBULIN G; PLASMA PROTEIN; PROTEIN C; PROTHROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; AUTOMATION; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; CRYOPRESERVATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; PLASMA VOLUME; PLASMAPHERESIS;

BLOOD BANKS; BLOOD COAGULATION FACTORS; BLOOD PRESERVATION; BLOOD PROTEINS; CITRIC ACID; CRYOPRESERVATION; GERMANY; HUMANS; IMMUNOGLOBULIN G; PLASMA; PLASMAPHERESIS; PRACTICE GUIDELINES; UNITED STATES;

EID: 0035689216     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41121601.x     Document Type: Article

References (19)

1. Current plasmapheresis practices in the United States
2. Collection of source material from remunerated donors
3. Safety and long-term effects of plasmapheresis
4. Long-term plasmapheresis: Effects on specific plasma proteins
5. Short-term and long-term effects of plasmapheresis on serum proteins and immunoglobulins
6. Pilot scale (300 kg) fractionation of plasma for factor VIII and factor IX
7. Quality of plasma for fractionation-does it matter?
8. Effect of citrate anticoagulants on factor VIII levels in plasma
9. The effect of citrate anticoagulants on apheresed plasma
10. Freezing of plasma and recovery of factor VIII
11. The plasma concentration of factor VIII in the normal population: II. The effects of age, sex and blood group
12. Factor VIII concentrate prepared from blood donors stimulated by intranasal administration of a vasopressin analogue
13. The potential impact of recombinant factor VIII on hemophilia care and the demand for blood and blood products
14. Comparison of manual and machine plasmapheresis techniques
15. Clinical application of a chromogenic substrate method for determination of factor VIII activity
16. Activated factor VIII in therapeutic preparations: Analysis by ultracentrifugation
17. Freezing technique and quality of fresh-frozen plasma